Haddjeri N, Blier P
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Synapse. 1995 May;20(1):54-67. doi: 10.1002/syn.890200109.
Microiontophoretic applications of 5-HT and of the 5-HT3 agonist 2-methyl-5-HT produced a current-dependent suppression of firing activity of both hippocampal (CA1 and CA3) and cortical neurons in anesthetized rats. Concomitant microiontophoretic applications of the 5-HT3 antagonists BRL 46470A and S-zacopride, as well as their intravenous injection, did not antagonize the inhibitory effect of 5-HT and 2-methyl-5-HT. In contrast, the 5-HT1A antagonist BMY 7378, applied by microiontophoresis or administered intravenously, significantly reduced the inhibitory action of 5-HT and 2-methyl-5-HT. The firing activity of dorsal raphe 5-HT neurons was also reduced by 5-HT, 2-methyl-5-HT and the 5-HT1A agonist 8-OH-DPAT applied by microiontophoresis. While BRL 46470A (0.1 and 1 mg/kg, i.v.) did not antagonize the inhibitory effect of the three 5-HT agonists on 5-HT neuronal firing activity, only that of 8-OH-DPAT was attenuated by the 5-HT1A antagonist (+) WAY 100135. R-zacopride significantly reduced the duration of suppression of firing activity of CA3 pyramidal neurons induced by the electrical stimulation of the ascending 5-HT pathway, and this reducing effect was prevented by the three 5-HT3/5-HT4 antagonists renzapride, S-zacopride and tropisetron, but not by BRL 46470A. Finally, in in vitro superfusion experiments, both BRL 46470A and S-zacopride antagonized the enhancing action of 2-methyl-5-HT on the electrically-evoked release of [3H]-5-HT in both rat frontal cortex and hippocampus slices. These findings suggest that, in vivo, the suppressant effect of 2-methyl-5-HT on the firing activity of dorsal hippocampus pyramidal, somatosensory cortical, and dorsal raphe 5-HT neurons is not mediated by 5-HT3 receptors, but rather by 5-HT1A receptors. The attenuating effect of R-zacopride on the effectiveness of the stimulation of the ascending 5-HT pathway is not mediated by 5-HT3 receptors. In contrast, in vitro, the enhancing action of 2-methyl-5-HT on the electrically-evoked release of [3H]5-HT in both frontal cortex and hippocampus slices is mediated by 5-HT3 receptors.
在麻醉大鼠中,5-羟色胺(5-HT)和5-HT3激动剂2-甲基-5-HT的微量离子导入应用导致海马体(CA1和CA3)和皮质神经元的放电活动出现电流依赖性抑制。同时进行5-HT3拮抗剂BRL 46470A和S-扎考必利的微量离子导入应用以及静脉注射,均未拮抗5-HT和2-甲基-5-HT的抑制作用。相比之下,通过微量离子导入或静脉注射应用的5-HT1A拮抗剂BMY 7378显著降低了5-HT和2-甲基-5-HT的抑制作用。通过微量离子导入应用5-HT、2-甲基-5-HT和5-HT1A激动剂8-羟基二丙胺基四氢萘(8-OH-DPAT)也降低了中缝背核5-HT神经元的放电活动。虽然BRL 46470A(0.1和1毫克/千克,静脉注射)未拮抗这三种5-HT激动剂对5-HT神经元放电活动的抑制作用,但只有8-OH-DPAT的抑制作用被5-HT1A拮抗剂(+)WAY 100135减弱。R-扎考必利显著缩短了由5-HT上行通路电刺激诱导的CA3锥体神经元放电活动抑制的持续时间,并且这种缩短作用被三种5-HT3/5-HT4拮抗剂瑞扎曲普坦、S-扎考必利和托烷司琼阻断,但未被BRL 46470A阻断。最后,在体外灌流实验中,BRL 46470A和S-扎考必利均拮抗了2-甲基-5-HT对大鼠额叶皮质和海马体切片中电诱发的[3H]-5-HT释放的增强作用。这些发现表明,在体内,2-甲基-5-HT对海马体背侧锥体、体感皮质和中缝背核5-HT神经元放电活动的抑制作用不是由5-HT3受体介导的,而是由5-HT1A受体介导的。R-扎考必利对5-HT上行通路刺激效果的减弱作用不是由5-HT3受体介导的。相比之下,在体外,2-甲基-5-HT对额叶皮质和海马体切片中电诱发的[3H]5-HT释放的增强作用是由5-HT3受体介导的。